CARE consortium dispatches to quicken drug discovery and improvement for COVID-19 Kumar Jeetendra | August 19, 2020 Using a grant approximately $77.7 million, CARE is funded by cash donations by the European Union (EU) and money and in-kind contributions from Australian European Federation of Pharmaceutical Industries and Associations (EFPIA) businesses and three IMI-Associated Partners. CARE is a five-year project bringing together 37 partners from Belgium, China, Denmark, France, Germany, the Netherlands, Poland, …
Key China COVID-19 examination delivered results that affected ensuing exploration on Covid Kumar Jeetendra | September 18, 2020 Crucial China COVID-19 study produced results that Affected subsequent research on coronavirus Early in the start of the COVID-19 pandemic, a small study in China produced results that affected subsequent research on the virus. Researchers at the University of Cincinnati used the same research parameters on a much larger patient population and reached completely different …
Enormous transporter protein dysfunction related with schizophrenia Kumar Jeetendra | December 29, 2020 Researchers have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it hard to show this and to pinpoint how it happens. Currently, Kazumitsu Ueda of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleagues in Japan have provided evidence that mice with disrupted ABCA13 protein demonstrate …
Pancreatic β cell-inferred exosomal miR-29s control glucose homeostasis Kumar Jeetendra | January 24, 2021 In a new study published in Journal of Extracellular Vesicles, Chen-Yu Zhang’s team at Nanjing University, School of Life Sciences, and Antonio Vidal-Puig’s group at University of Cambridge report that pancreatic β cells secrete miR-29 family members (miR-29s) via exosomes in reaction to high levels of free fatty acids (FFAs). Formerly, Chen-Yu Zhang’s team identified …
